Influence of Neck Design on Peri-implant Hard and Soft Tissues

December 13, 2023 updated by: Jordi caballé, Universitat Internacional de Catalunya

The goal of this clinical trial is to test two different implant neck designs in 36 patients. The main question[s] it aims to answer are:

  • do triangular neck designed implants placed immediately after dental extraction have the same influence on peri-implant hard and soft tissues than regular neck designed implants at one year?
  • do triangular neck designed implants placed immediately after dental extraction have the same influence on peri-implant hard and soft tissues than regular neck designed implants at three years?

Participants that present an unrepairable tooth on the anterior upper maxilla will be asked to take a CBCT scan in order to verify the presence of the buccal bone. Once this is verified the patients will enter in the study and the day of the surgery they will be assigned to either control or test group.

  • Control group: C1 round-neck implant
  • Test groups: V3 triangular-implant neck

Researchers will compare test and control groups to see if they have the same effects on hard and soft tissues at 4 months, 1 year and 3 years.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Immediate implant placement is considered to be a technique-sensitive protocol with a variety of potential risks. The interface area between the neck of the implant and the abutment is critical; it can affect the treatment outcome, particularly mar-ginal bone loss (MBL) and soft tissue behavior. Traditionally, the implant neck is circu-lar in shape; however, a new triangular neck design has recently been introduced on the market, though advanced indications of this innovative design are still lacking.

The objective of this randomized clinical trial was to compare the clinical and radiographic outcomes obtained after immediate placement of implants and temporization of two different neck geometries: a traditional round neck (RN) and an innovative neck with a triangular shape (TN).

Study Type

Interventional

Enrollment (Actual)

36

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Barcelona
      • Sant Cugat Del Vallès, Barcelona, Spain, 08195
        • Universitat Internacional de Catalunya

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • healthy non-smokers or light smokers (< 10 cigarettes/day)
  • adults (> 18 years of age),
  • need for single tooth extraction of a maxillary incisor, canine or premolar
  • adequate oral hygiene
  • ability to follow instructions and attend the required appointments
  • presence of a length of at least 3 mm of buccal bone measuring ≥ 0.5 mm in thickness, apical to the extraction socket
  • stable and intact socket walls

Exclusion Criteria:

  • patients with acute infections in the area of interest
  • individuals with large occlusal discrepancies and/or occlusal overload para-functions
  • smokers of more than 10 cigarettes/day
  • patients with any medical condition or medication contraindicating dental implant treatment

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: V3 Implant MIS Iberica
Implant with triangular neck macro design
Placement of immediate implant and immediate provisionalization after tooth extraction
Active Comparator: C1 Implant MIS Iberica
Implant with circular neck macro design
Placement of immediate implant and immediate provisionalization after tooth extraction

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Buccal bone width (BBW)
Time Frame: 4 months
buccal bone width was measured by CBCT (iCAT®, Imaging Science International, LLC, Hatfield, PA, USA) at four points: at the implant neck, and at 1 mm, 2 mm and 3 mm above the implant neck.
4 months
Marginal bone loss (MBL)
Time Frame: 4 months
marginal bone loss was measured on mesial and distal aspects of the implant using intraoral standardized periapical radiographs with the parallel technique. Measurements were performed using K-Pacs Work-station (Image Information Systems, Ltd.). The distance from the implant shoulder to the first bone-implant contact was measured at the mesial and distal sites.
4 months
Marginal bone loss (MBL)
Time Frame: 1 years
marginal bone loss was measured on mesial and distal aspects of the implant using intraoral standardized periapical radiographs with the parallel technique. Measurements were performed using K-Pacs Work-station (Image Information Systems, Ltd.). The distance from the implant shoulder to the first bone-implant contact was measured at the mesial and distal sites.
1 years
Marginal bone loss (MBL)
Time Frame: 3 years
marginal bone loss was measured on mesial and distal aspects of the implant using intraoral standardized periapical radiographs with the parallel technique. Measurements were performed using K-Pacs Work-station (Image Information Systems, Ltd.). The distance from the implant shoulder to the first bone-implant contact was measured at the mesial and distal sites.
3 years
Soft tissue thickness (STT)
Time Frame: 4 months
the thickness of the buccal soft tissue at 3 mm and 5 mm from the gingi-val margin was measured using an endodontic file.
4 months
Soft tissue thickness (STT)
Time Frame: 1 years
the thickness of the buccal soft tissue at 3 mm and 5 mm from the gingi-val margin was measured using an endodontic file.
1 years
Soft tissue thickness (STT)
Time Frame: 3 years
the thickness of the buccal soft tissue at 3 mm and 5 mm from the gingi-val margin was measured using an endodontic file.
3 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Insertion torque (IT):
Time Frame: day 1
the insertion torque of the implant was measured on the day of the sur-gery with the implant motor.
day 1
ISQ (implant stability quotient):
Time Frame: day 1
the ISQ was measured at implant placement using the Osstell device, which involves resonance frequency analysis (RFA) for measuring the fre-quency of vibration.
day 1
Probing pocket depth (PPD):
Time Frame: 4 months
probing pocket depth was measured with a Marquis Color code dental probe at 6 sites covering 360ª of the tooth: three on the buccal site and three on the palatal site of each tooth.
4 months
Probing pocket depth (PPD):
Time Frame: 1 year
probing pocket depth was measured with a Marquis Color code dental probe at 6 sites covering 360ª of the tooth: three on the buccal site and three on the palatal site of each tooth.
1 year
Probing pocket depth (PPD):
Time Frame: 3 year
probing pocket depth was measured with a Marquis Color code dental probe at 6 sites covering 360ª of the tooth: three on the buccal site and three on the palatal site of each tooth.
3 year
Bleeding on probing (BOP):
Time Frame: 4 months
bleeding on probing was registered at each PPD site, whether there was bleeding or not.
4 months
Bleeding on probing (BOP):
Time Frame: 1 year
bleeding on probing was registered at each PPD site, whether there was bleeding or not.
1 year
Bleeding on probing (BOP):
Time Frame: 3 year
bleeding on probing was registered at each PPD site, whether there was bleeding or not.
3 year
Crestal width (CW)
Time Frame: 4 months
at 3 mm and 5 mm from the gingival margin: a gauge compass was used to measure the whole width of the crestal volume, from palatal to ves-tibular wall.
4 months
Crestal width (CW)
Time Frame: 1 year
at 3 mm and 5 mm from the gingival margin: a gauge compass was used to measure the whole width of the crestal volume, from palatal to ves-tibular wall.
1 year
Crestal width (CW)
Time Frame: 3 year
at 3 mm and 5 mm from the gingival margin: a gauge compass was used to measure the whole width of the crestal volume, from palatal to ves-tibular wall.
3 year
Pink esthetic score (PES):
Time Frame: 4 months
this score was measured based on the Furhauser table. Maximum: 14 points / Minimum: 0 points. Higher scores mean a better outcome.
4 months
Pink esthetic score (PES):
Time Frame: 1 year
this score was measured based on the Furhauser table. Maximum: 14 points / Minimum: 0 points. Higher scores mean a better outcome.
1 year
Pink esthetic score (PES):
Time Frame: 3 year
this score was measured based on the Furhauser table. Maximum: 14 points / Minimum: 0 points. Higher scores mean a better outcome.
3 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: CRISTINA PORTA FERRER, Universitat Internacional de Catalunya

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 15, 2016

Primary Completion (Actual)

September 15, 2023

Study Completion (Actual)

September 15, 2023

Study Registration Dates

First Submitted

June 7, 2023

First Submitted That Met QC Criteria

July 5, 2023

First Posted (Actual)

July 13, 2023

Study Record Updates

Last Update Posted (Estimated)

December 14, 2023

Last Update Submitted That Met QC Criteria

December 13, 2023

Last Verified

December 1, 2023

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Bone Resorption

Clinical Trials on Immediate implant surgery

Subscribe